Search results for "EMT"

showing 10 items of 413 documents

Investigation of the p–Σ0 interaction via femtoscopy in pp collisions

2020

This Letter presents the first direct investigation of the p-$\Sigma^{0}$ interaction, using the femtoscopy technique in high-multiplicity pp collisions at $\sqrt{s}$ = 13 TeV measured by the ALICE detector. The $\Sigma^{0}$ is reconstructed via the decay channel to $\Lambda \gamma$, and the subsequent decay of $\Lambda$ to p$\pi^-$. The photon is detected via the conversion in material to e$^{+}$e$^{-}$ pairs exploiting the unique capability of the ALICE detector to measure electrons at low transverse momenta. The measured p-$\Sigma^{0}$ correlation indicates a shallow strong interaction. The comparison of the data to several theoretical predictions obtained employing the $Correlation~Anal…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Photonp-S0 interaction femtoscopy pp collisionshypernucleuslow [transverse momentum]Electronspin01 natural sciencesHigh Energy Physics - ExperimentALICECorrelation functionscattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]correlation functionNuclear ExperimentNuclear ExperimentSpin-½Physicsp-S0 interactionPhysicsstrong interactionphotonVDP::Kjerne- og elementærpartikkelfysikk: 431lcsh:QC1-999PRIRODNE ZNANOSTI. Fizika.:Nuclear and elementary particle physics: 431 [VDP]CERN LHC CollVDP::Nuclear and elementary particle physics: 431Isospinpp collisionsNuclear and High Energy Physicsp p: scatteringtransverse momentum: lowStrong interaction[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]BOUND-STATE530114 Physical sciencesALICE; femtoscopyquarkNuclear physicsisospin0103 physical sciencesfemtoscopyddc:530010306 general physicsplasmaALICE LHC010308 nuclear & particles physicsScatteringHypernuclei Neutron Stars StrangenessgluonHypernucleusNATURAL SCIENCES. Physics.13000 GeV-cms/nucleoncorrelationquark; gluon; plasmafemtoscopy ; pp collisionslcsh:Physicsexperimental results
researchProduct

Scattering Studies with Low-Energy Kaon-Proton Femtoscopy in Proton-Proton Collisions at the LHC

2020

The study of the strength and behaviour of the antikaon-nucleon ($\mathrm{\overline{K}N}$) interaction constitutes one of the key focuses of the strangeness sector in low-energy Quantum Chromodynamics (QCD). In this letter a unique high-precision measurement of the strong interaction between kaons and protons, close and above the kinematic threshold, is presented. The femtoscopic measurements of the correlation function at low pair-frame relative momentum of (K$^+$ p $\oplus$ K$^-$ $\overline{\mathrm{p}}$) and (K$^-$ p $\oplus$ K$^+$ $\overline{\mathrm{p}}$) pairs measured in pp collisions at $\sqrt{s}$ = 5, 7 and 13 TeV are reported. A structure observed around a relative momentum of 58 Me…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Protonchiral dynamicsGeneral Physics and Astronomyhiukkasfysiikkanucl-ex01 natural sciencesHigh Energy Physics - ExperimentHigh Energy Physics - Experiment (hep-ex)ALICELHC HBTCorrelation functionHBT[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]scattering [p p]correlation functionKaon-ProtonNuclear Experiment (nucl-ex)Nuclear ExperimentNuclear ExperimentQuantum chromodynamicsPhysicsLarge Hadron ColliderPhysicsstrong interactionCHIRAL DYNAMICSVDP::Kjerne- og elementærpartikkelfysikk: 431SIGMA-HYPERON PRODUCTIONddc:3. Good healthPRIRODNE ZNANOSTI. Fizika.p interactions:Nuclear and elementary particle physics: 431 [VDP]CERN LHC CollNUCLEON INTERACTIONSVDP::Nuclear and elementary particle physics: 431P INTERACTIONSIsospinLHC5000 GeV-cms/nucleon 7000 GeV-cms/nucleon 13000 GeV-cms/nucleonpp collisionsParticle Physics - Experimentp p: scatteringStrong interactionLAMBDA(1405)Kaon-Proton Femtoscopy pp collisions LHCFOS: Physical sciences[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Physics and Astronomy(all)Strangenesslambda(1405)114 Physical sciencesALICE; femtoscopyp-pNuclear physicsMomentumALICE LHC High-Energy Physicschiral [model]strangenessnucleon interactionsKaon-Proton ; Femtoscopy ; p-pfemtoscopyquantum chromodynamics0103 physical sciencesNuclear Physics - Experimentddc:530010306 general physicsNuclear Physicsanti-K nucleon: interactionhep-exHigh Energy Physics::PhenomenologySIGMA-HYPERON PRODUCTION; NUCLEON INTERACTIONS; CHIRAL DYNAMICS; P INTERACTIONS; LAMBDA(1405)interaction [anti-K nucleon]mass differenceNATURAL SCIENCES. Physics.Kaon-Proton Femtoscopysigma-hyperon productionHigh Energy Physics::Experimentmodel: chiralexperimental results
researchProduct

Giant hepatocellular adenoma as cause of severe abdominal pain: a case report

2007

Abstract The authors describe the case of a large hepatocellular adenoma diagnosed in a 30-year old woman who came to us complaining of acute pain in the upper abdominal quadrants. The patient had been taking an oral contraceptive pill for the last ten years. We present the clinical features, the diagnostic work-up and the treatment prescribed.

Abdominal painPathologyoral contraceptive agent EMTREE medical terms: abdominal painanamnesilcsh:Medicinecomputer assisted tomographyaspartate aminotransferaseSurgical oncologynuclear magnetic resonance imagingMedicine(all)oral contraceptionadultarticleGeneral MedicineAbdominal quadrantsfemalepriority journalhistopathologycontrast enhancementdisease severitymedicine.symptomEMTREE drug terms: alanine aminotransferasemedicine.medical_specialtyOral contraceptive pillcontrast mediummedicinediffusion weighted imagingcase reportfollow uphumanAcute painliver biopsydrug useliver lobectomybusiness.industryGeneral surgeryPublic healthlcsh:RechographyHepatocellular adenomaliver angiographymedicine.diseasetumor bleedinghuman tissueclinical featurenausea and vomitingbusinessaspartate aminotransferase blood levelliver adenomaalanine aminotransferase blood level
researchProduct

Femtosecond up-conversion technique for probing the charge transfer in a P3HT : PCBM blend via photoluminescence quenching

2009

We report on an experimental study of the charge transfer dynamics in a P3HT : PCBM blend by means of a femtosecond fluorescence up-conversion technique. Using two-photon excitation we probe the exciton dynamics in P3HT and a P3HT : PCBM blend with a weight ratio of 1 : 1 at excitation densities of up to 6 × 1018 cm−3. In both samples we find strongly nonexponential decay traces compatible with (i) diffusion-limited exciton–exciton annihilation and (ii) diffusion-limited donor–acceptor charge transfer in the polymer blend. Additionally, our results indicate that in the P3HT : PCBM blend about 50% of the photogenerated excitons undergo a prompt charge transfer process on a time scale of abou…

Acoustics and UltrasonicsChemistryExcitonCondensed Matter PhysicsPhotochemistryFluorescenceFluorescence spectroscopySurfaces Coatings and FilmsElectronic Optical and Magnetic Materialslaw.inventionChemical physicslawSolar cellFemtosecondPolymer blendUltrashort pulseExcitationJournal of Physics D: Applied Physics
researchProduct

Serotherapy with thymoglobulin and alemtuzumab differentially influences frequency and function of natural killer cells after allogeneic stem cell tr…

2007

Although thymoglobulin and alemtuzumab are frequently used in hematopoietic stem cell transplantation (HSCT), little is known of their effects on NK cells, which mediate important functions in post-transplantation immunology. In the present study, we determined NK cell death in vitro using propidium iodide and Annexin V. The NK cell activity in 34 patients at day +30 after allogeneic HSCT was assessed using the CD107a assay. Alemtuzumab and thymoglobulin were similarly very potent in inducing NK cell death in vitro. Even in low concentrations (1 microg/ml) the antibodies induced apoptosis and necrosis in a relevant percentage of NK cells (30%). However, the number of tumor reactive (CD107a+…

AdultAdolescentAntibodies Neoplasmmedicine.medical_treatmentApoptosisHematopoietic stem cell transplantationAntibodies Monoclonal HumanizedLymphocyte DepletionNatural killer cellCell Line TumormedicineHumansTransplantation HomologousProgenitor cellAlemtuzumabAgedAntilymphocyte SerumTransplantationCell DeathThymoglobulinbusiness.industryHematopoietic Stem Cell TransplantationAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseKiller Cells NaturalTransplantationmedicine.anatomical_structureGraft-versus-host diseaseImmunologyAlemtuzumabStem cellbusinessImmunosuppressive Agentsmedicine.drugBone Marrow Transplantation
researchProduct

A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas

2010

The clinical course of peripheral T-cell lymphoma (PTCL) is usually aggressive and the prognosis unfavorable. Therefore, there is a need for improvement of treatment options. Patients with newly diagnosed (n = 27) or refractory/relapsed (n = 11) PTCL received a combination of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin. The overall response rate (ORR) was 61%, with a complete response rate of 39%. In newly diagnosed patients the ORR was 63%, the median overall survival 25.9 months, and progression-free survival 11.8 months. In relapsed/refractory patients the median OS was 6.1 months. The most frequent grade 3/4 toxicities were leukopenia (95% of patients) and thrombocytopen…

AdultMaleCancer Researchmedicine.medical_specialtyCyclophosphamideAntibodies Neoplasmmedicine.medical_treatmentPhases of clinical researchAntibodies Monoclonal HumanizedLymphoma T-CellGastroenterologyDisease-Free SurvivalRefractoryRecurrenceInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansAlemtuzumabCyclophosphamideAgedChemotherapyLeukopeniabusiness.industryAntibodies MonoclonalHematologyMiddle Agedmedicine.diseaseLymphomaFludarabineSurgeryTreatment OutcomeOncologyDoxorubicinAlemtuzumabFemalemedicine.symptombusinessVidarabinemedicine.drugLeukemia & Lymphoma
researchProduct

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence

2005

BACKGROUND In this study, the authors analyzed the efficacy and safety of gemtuzumab ozogamicin (GO) (Mylotarg®), an antibody-targeted chemotherapy for CD33-positive acute myeloid leukemia (AML). METHODS Patients with CD33-positive AML in first recurrence were entered in 3 open-label, single-arm, Phase II studies. Patients received monotherapy with GO 9 mg/m2 as a 2-hour intravenous infusion in 2 doses separated by 2 weeks. Patients were evaluated for remission, survival, and treatment-emergent adverse events. RESULTS Two hundred seventy-seven patients (median age, 61 yrs) were treated with GO, and 71 patients (26%) achieved remission, which was defined as ≤ 5% blasts in the bone marrow wit…

AdultMaleCancer Researchmedicine.medical_specialtyMyeloidMaximum Tolerated DoseGemtuzumab ozogamicinmedicine.medical_treatmentCD33Sialic Acid Binding Ig-like Lectin 3Antigens Differentiation MyelomonocyticHematopoietic stem cell transplantationNeutropeniaAntibodies Monoclonal HumanizedGastroenterologyRisk AssessmentSeverity of Illness IndexDrug Administration ScheduleClinical Trials Phase II as TopicAntigens CDRecurrenceInternal medicinemedicineHumansSingle-Blind MethodSurvival rateAgedAged 80 and overChemotherapyDose-Response Relationship Drugbusiness.industryAntibodies MonoclonalMiddle Agedmedicine.diseaseGemtuzumabSurgerySurvival RateLeukemiaLeukemia Myeloid Acutemedicine.anatomical_structureAminoglycosidesTreatment OutcomeOncologyEvaluation Studies as TopicFemalebusinessmedicine.drugFollow-Up StudiesCancer
researchProduct

CD52‐negative T cells predict acute graft‐versus‐host disease after an alemtuzumab‐based conditioning regimen

2020

Allogeneic haematopoietic stem cell transplantation (HSCT) after a reduced-intensity conditioning (RIC) regimen with fludarabine, melphalan and alemtuzmab is an effective therapy for haematological malignancies. Alemtuzumab, a monoclonal antibody against CD52, a glycosylphosphatidylinositol-anchor-bound surface protein on lymphocytes, depletes T cells to prevent graft-versus-host disease (GVHD). Despite this, acute and chronic GVHD (a/cGVHD) remain life-threatening complications after HSCT. The aim of the present study was to identify parameters to predict GVHD. In 69 patients after HSCT, T-cell subsets were functionally analysed. Reconstitution of CD52neg T cells and CD52neg regulatory T c…

AdultMaleMelphalanReceptors CXCR3Transplantation ConditioningReceptors CCR5CD52Graft vs Host Diseasechemical and pharmacologic phenomenaCXCR3T-Lymphocytes Regulatory03 medical and health sciences0302 clinical medicineRisk Factorsimmune system diseaseshemic and lymphatic diseasesmedicineHumansAlemtuzumabAgedbusiness.industryHematopoietic Stem Cell TransplantationMembrane ProteinsHematologyMiddle AgedAllograftsFludarabineTransplantationHaematopoiesissurgical procedures operativeCD52 Antigen030220 oncology & carcinogenesisAcute DiseaseImmunologyAlemtuzumabFemaleStem cellbusiness030215 immunologymedicine.drugBritish Journal of Haematology
researchProduct

Airway epithelial dysfunction and mesenchymal transition in chronic obstructive pulmonary disease: Role of Oct-4

2021

Abstract The airway epithelium is a dynamic tissue that undergoes slow but constant renewal. Dysregulation of airway epithelial function related to cigarette smoke exposure plays an important role in the pathophysiology of COPD. Oct4 is a transcription factor responsible for maintaining cellular self-renewal and regeneration, and CD146 and CD105/Endoglin are adhesion molecules involved in cell proliferation, differentiation, epithelial-mesenchymal-transition and tissue remodeling. Bronchial biopsy specimens (BBs) were obtained from 7 healthy controls (HC) and 10 COPD and subjected to paraffin embedding; BBs from HC were also used for epithelial cell expansion and pHBEC/ALI (air-liquid inter…

AdultMalePathologymedicine.medical_specialtyEMT (epithelial-mesenchymal transition)Epithelial-Mesenchymal TransitionRespiratory SystemOct-4CD146 AntigenGeneral Biochemistry Genetics and Molecular BiologyCigarette SmokingPulmonary Disease Chronic ObstructiveAirway epithelium de-differentiationHumansMedicineGeneral Pharmacology Toxicology and PharmaceuticsAgedCOPDbusiness.industryCell adhesion moleculeMesenchymal stem cellEndoglinCell DifferentiationGeneral MedicineMiddle AgedEndoglinmedicine.diseaseCigarette smoke exposureEpitheliumrespiratory tract diseasesCD105medicine.anatomical_structureCD146Case-Control StudiesImmunohistochemistryRespiratory epitheliumCD146FemalebusinessOctamer Transcription Factor-3Life Sciences
researchProduct

Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell–depleted reduced-intensity transplantation

2006

AbstractAllogeneic hematopoietic stem cell transplantation (SCT) regimens incorporating the lymphocytotoxic CD52 antibody alemtuzumab demonstrate efficient engraftment and reduced graft-versus-host disease (GVHD). However, these protocols substantially impair posttransplantation antiviral and antitumor immunity. To accelerate immune reconstitution after alemtuzumab-based reduced-intensity SCT, we administered prophylactic CD8-depleted donor lymphocyte infusions (DLIs) starting on days 60 and 120 after transplantation. DLIs were processed in an immunomagnetic good manufacturing practice depletion procedure resulting in a 2.5- to 6-log reduction in CD8 T cells. Of 23 high-risk patients with h…

AdultMaleTransplantation ConditioningCD52Antibodies Neoplasmmedicine.medical_treatmentT cellImmunologyGraft vs Host DiseaseHematopoietic stem cell transplantationCD8-Positive T-LymphocytesAntibodies Monoclonal HumanizedImmunotherapy AdoptiveBiochemistryLymphocyte DepletionHLA AntigensmedicineHumansCytotoxic T cellAlemtuzumabPeripheral Blood Stem Cell TransplantationImmunomagnetic Separationbusiness.industryGraft SurvivalAntibodies MonoclonalCell BiologyHematologyMiddle AgedDonor Lymphocytesmedicine.diseaseTransplantationTreatment Outcomesurgical procedures operativeGraft-versus-host diseasemedicine.anatomical_structureHematologic NeoplasmsLangerhans CellsImmunologyAlemtuzumabFemaleK562 CellsbusinessFollow-Up Studiesmedicine.drugBlood
researchProduct